Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

Lilly(Eli) (LEL)

Lilly(Eli)
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:LEL
DateTimeSourceHeadlineSymbolCompany
30/01/201414:27PR Newswire (US)LILLY (ELI) & COMPANY - 4th Quarter EarningsLSE:LELLilly(Eli)
25/07/201306:00PR Newswire (US)LILLY (ELI) & COMPANY - Half-yearly ReportLSE:LELLilly(Eli)
08/07/201314:17PR Newswire (US)LILLY (ELI) & COMPANY - Form 8-KLSE:LELLilly(Eli)
08/05/201314:06PR Newswire (US)LILLY (ELI) & COMPANY - Doc re Form 8K FilingLSE:LELLilly(Eli)
07/05/201314:22PR Newswire (US)LILLY (ELI) & COMPANY - CEO Lechleiter to undergo surgeryLSE:LELLilly(Eli)
03/05/201306:00PR Newswire (US)LILLY (ELI) & COMPANY - Doc re Proxy StatementsLSE:LELLilly(Eli)
03/05/201306:00PR Newswire (US)LILLY (ELI) & COMPANY - 1st Quarter ResultsLSE:LELLilly(Eli)
24/04/201315:31PR Newswire (US)LILLY (ELI) & COMPANY - Doc re Form 8-K FilingLSE:LELLilly(Eli)
28/03/201313:35UK RegulatoryLilly (Eli) & Co Cancellation of ListingLSE:LELLilly(Eli)
28/03/201313:35PR Newswire (US)LILLY (ELI) & COMPANY - Cancellation of ListingLSE:LELLilly(Eli)
28/03/201308:00UK RegulatoryOfficial List Cancellation Lilly (Eli) & CompanyLSE:LELLilly(Eli)
26/03/201316:01PR Newswire (US)LILLY (ELI) & COMPANY - Doc re Proxy StatementsLSE:LELLilly(Eli)
26/03/201316:00PR Newswire (US)LILLY (ELI) & COMPANY - Statement re Intention to Cancel Listing of SharesLSE:LELLilly(Eli)
27/02/201317:06PR Newswire (US)LILLY (ELI) & COMPANY - Statement re Intention to Cancel ListingLSE:LELLilly(Eli)
07/02/201313:59PR Newswire (US)LILLY (ELI) & COMPANY - Phase 3 RA Program discontinued for TabalumabLSE:LELLilly(Eli)
29/01/201313:33PR Newswire (US)LILLY (ELI) & COMPANY - Lilly Reports Q4 and Full-Year 2012 ResultsLSE:LELLilly(Eli)
24/01/201318:24PR Newswire (US)LILLY (ELI) & COMPANY - Miscellaneous - Other SEC FilingsLSE:LELLilly(Eli)
24/01/201318:22PR Newswire (US)LILLY (ELI) & COMPANY - Holding(s) in CompanyLSE:LELLilly(Eli)
24/01/201318:21PR Newswire (US)LILLY (ELI) & COMPANY - Doc re Form 8-K FilingsLSE:LELLilly(Eli)
24/01/201318:19PR Newswire (US)LILLY (ELI) & COMPANY - Director/PDMR ShareholdingLSE:LELLilly(Eli)
24/01/201318:16PR Newswire (US)LILLY (ELI) & COMPANY - Doc re Proxy StatementLSE:LELLilly(Eli)
24/01/201318:15PR Newswire (US)LILLY (ELI) & COMPANY - 3rd Quarter ResultsLSE:LELLilly(Eli)
24/01/201318:13PR Newswire (US)LILLY (ELI) & COMPANY - 1st Quarter ResultsLSE:LELLilly(Eli)
24/01/201318:12PR Newswire (US)LILLY (ELI) & COMPANY - Half-yearly ReportLSE:LELLilly(Eli)
24/01/201318:11PR Newswire (US)LILLY (ELI) & COMPANY - Annual Financial ReportLSE:LELLilly(Eli)
24/01/201318:02PR Newswire (US)LILLY (ELI) & COMPANY - Annual Information Update 2012LSE:LELLilly(Eli)
24/01/201317:39PR Newswire (US)LILLY (ELI) & COMPANY - Annual Information Update 2011LSE:LELLilly(Eli)
24/01/201317:37PR Newswire (US)LILLY (ELI) & COMPANY - Annual Information Update 2010LSE:LELLilly(Eli)
16/01/201307:00PR Newswire (US)LILLY (ELI) & COMPANY - Amyvid Approved in European UnionLSE:LELLilly(Eli)
07/01/201314:11PR Newswire (US)LILLY (ELI) & COMPANY - Phase III data results for empagliflozinLSE:LELLilly(Eli)
 Showing the most relevant articles for your search:LSE:LEL